adjuvant sunitinib’s role in the treatment of rcc
Published 6 years ago • 429 plays • Length 5:54Download video MP4
Download video MP3
Similar videos
-
1:35
dr. george on the use of adjuvant sunitinib in rcc
-
19:55
adjuvant sunitinib for high risk renal cell carcinoma: not ready for prime time
-
1:03
dr. barocas on adjuvant sunitinib in renal cell carcinoma
-
2:20
dr. lara on the fda approval of adjuvant sunitinib in rcc
-
7:18
vegf tki therapy in the adjuvant setting of rcc
-
0:53
the role of icis in the adjuvant setting for rcc
-
1:23
dr. lara on the role of sunitinib for renal cell carcinoma
-
2:11
dr. haas on adjuvant sorafenib or sunitinib for rcc
-
3:00
adjuvant sunitinib in renal cell carcinoma
-
5:56
recent data in the adjuvant setting of rcc
-
6:57
dosing schedule of sunitinib in renal cell carcinoma
-
3:49
adjuvant sunitinib for renal cell carcinoma
-
2:23
s-trac phase iii trial of sunitinib as adjuvant therapy in high-risk renal cell cancer patients
-
8:11
implications of using adjuvant sorafenib and sunitinib in unfavourable renal carcinoma
-
0:45
daniel j. george, md, on the effectiveness of sunitinib in the adjuvant treatment of high-risk rcc
-
4:03
adjuvant treatment with sorafenib or sunitinib doesn't improve outcomes in localised renal carcinoma
-
1:56
sunitinib for treating high-risk rcc
-
1:16
dr. george on sunitinib in rcc
-
1:08
clinical trials in adjuvant rcc